» Articles » PMID: 3292790

High-level Eucaryotic in Vivo Expression of Biologically Active Measles Virus Hemagglutinin by Using an Adenovirus Type 5 Helper-free Vector System

Overview
Journal J Virol
Date 1988 Aug 1
PMID 3292790
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The entire measles virus (MV) hemagglutinin (HA)-coding region was reconstructed from cloned cDNAs and used as part of a hybrid transcription unit to replace a region of the adenovirus type 5 genome corresponding to the entire E1a transcription unit and most of the E1b transcription unit. The resulting recombinant virus was stable and able to replicate to high titers in 293 cells (which constitutively express the complementary E1a-E1b functions) in the absence of helper virus. During infection of 293 cells, the hybrid virus expressed MV HA protein which was indistinguishable from that expressed in MV-infected cells in terms of immunoreactivity, gel mobility, glycosylation, subcellular localization, and biologic activity. Infection of 293 cells with the hybrid virus led to high-level synthesis of the MV HA protein (equivalent to 65 to 130% of the level seen in MV-infected cells). At late times after high-multiplicity hybrid virus infection of HeLa and Vero cells (which do not express E1 functions), the level of HA protein synthesis was at least 35% of that seen in 293 cells. This MV-adenovirus recombinant will be useful in the study of the biologic properties of the MV HA protein and in assessment of the potential usefulness of hybrid adenoviruses as live-virus vaccine vectors.

Citing Articles

Future Prospects for the Development of Cost-Effective Adenovirus Vaccines.

Fougeroux C, Holst P Int J Mol Sci. 2017; 18(4).

PMID: 28420073 PMC: 5412272. DOI: 10.3390/ijms18040686.


Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.

Zhang J Viruses. 2012; 4(11):2711-35.

PMID: 23202501 PMC: 3509669. DOI: 10.3390/v4112711.


Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain.

Shim B, Stadler K, Nguyen H, Yun C, Kim D, Chang J Virol J. 2012; 9:215.

PMID: 22995185 PMC: 3489719. DOI: 10.1186/1743-422X-9-215.


Adenoviruses as vaccine vectors.

Tatsis N, Ertl H Mol Ther. 2004; 10(4):616-29.

PMID: 15451446 PMC: 7106330. DOI: 10.1016/j.ymthe.2004.07.013.


Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.

Agrawal L, Lu X, Qingwen J, Vanhorn-Ali Z, Nicolescu I, McDermott D J Virol. 2004; 78(5):2277-87.

PMID: 14963124 PMC: 369216. DOI: 10.1128/jvi.78.5.2277-2287.2004.


References
1.
Jones N, Shenk T . Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell. 1979; 17(3):683-9. DOI: 10.1016/0092-8674(79)90275-7. View

2.
Spriggs M, Murphy B, Prince G, Olmsted R, Collins P . Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. J Virol. 1987; 61(11):3416-23. PMC: 255937. DOI: 10.1128/JVI.61.11.3416-3423.1987. View

3.
Thomas P . Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A. 1980; 77(9):5201-5. PMC: 350025. DOI: 10.1073/pnas.77.9.5201. View

4.
Togashi T, Orvell C, Vartdal F, Norrby E . Production of antibodies against measles virions by use of the mouse hybridoma technique. Arch Virol. 1981; 67(2):149-57. DOI: 10.1007/BF01318598. View

5.
Thummel C, Tjian R, Grodzicker T . Expression of SV40 T antigen under control of adenovirus promoters. Cell. 1981; 23(3):825-36. DOI: 10.1016/0092-8674(81)90447-5. View